Earnings call transcript Q1 2023

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Good afternoon, everyone. And thank you for joining OptimizeRx’s First Quarter Fiscal 2023 Earnings Discussion. With us today is the Chief Executive Officer of OptimizeRx, Will Febbo. He is joined by company Chief Financial and Operating Officer, Ed Stelmakh; Chief Commercial Officer, Steve Silvestro; General Counsel and Chief Compliance Officer; Marion Odence-Ford; and Senior Vice President of Corporate Finance, Andrew D’Silva.

At the conclusion of today’s earnings call, some important cautions regarding the forward-looking statements made by management during today’s call will be provided. remind be today’s via made to recorded is webcast like will and available would everyone call that being only. I for replay the company’s included section are in press and Instructions today’s of website. in the release Investors

In financial that the believe today financial today’s they be reconciliation A release. will to addition, the financial aid press company’s found measures discuss can management of non-GAAP measures certain understanding results. in comparable GAAP in

Sir, please Now OptimizeRx Febbo. I’d like CEO, call turn ahead. to over go to the Will

Will Febbo

Thank fiscal thank first you, everyone. for you And Operator. Good XXXX afternoon, joining our quarter call. earnings

results in of $XX was quarter at first of QX our Our which in million. end top range were to our expectations came and million revenue the million, revenue with $XX at guidance line $XX.X

full result are revenue executing to our year-over-year our XX% a for calls at also we believe our year-over-year. by to end We which will in As topline guidance result, of outlook, increase XXXX. against the improvements KPIs our least year maintaining

pharma the to the While the now customer while to to crisis at to fully continue comfort there that implemented began trough QX the industry quarter, of the we focus and behind potential the return to that normalized, in be by This some despite was early were appears base macro the the us is emerge that case address banking environment and end short-lived. disruption was gained with normalcy. moved macro short-term second hasn’t our the overhang, top-down resolutions as towards understanding fallout. And by

the macro portion of if which, tactical headwinds most the we’ve seeing our impacted was modest discussed. was are We to recall, sales, improvements business transitory that by you

accessing a part being continue data themselves efficiently across provides with as while our significant to scale, us edge. physicians of macros on multiple able our believe to this back to work improve reach, pads landing ability competitive to focus expect and We out and the business report

continue revenue or of will are at RWD-AI gain this for believe to Data momentum our Real-World AI-Driven our and XX% offering XXXX. least and and revenue to for total we solution discussions from approach late-stage deals in importantly, More year-over-year continues XXX% increase multiple

is RWD-AI XXXX, and of on deals we’re coming types but XXX in of the brands. focus the top the a well. of view with significant pipeline We in Our not the for growth, positive as dozens in just comprised progress years as discussions our extremely

We as of believe to HCPs the messaging pack this AI-driven and while for it is are actionable solutions effectively insights in-workflow as patients. and in momentum no differentiate better our outcomes showcases the solutions RWD-AI truly our of driving proud pharma, ourselves, extremely I’m us other keeping and ability ahead there market. innovate

second year expansion examples seen We growth. of significant are and now full in of solution having market several have the in our RWD-AI and

to from type, our example, message channel $X For over was live several of extending now in to-date disease, largest represented programs, unique client scaled million. reach expansion exciting. that one it representing expansion and dimensions, very and our pilot three solutions multiyear This

robust single progress that expanding a omni-channel across and ROIs the we in our for our communications to Operationally, ability awareness shop also and superior drive resulting brands solutions. made pads created serve. building reputation tuck-in of landing acquisitions which and investments, We’ve offering, partnerships is have industry tremendous on the technology has multiple in our

solutions deliver fact the continue the are manage to United what special is the to largest makes network connectivity we to business the of digital that in able prescribers. States in workflow point-of-care part via our and Recall, model

of capturing will the the and greater To complement space coming portion have expanding result white EHR, a this, industry which quarters in outside believe we us available offerings in years. the been of service we

while solutions, $XX pinpointing new a billion of impactful also known towards moving looking for but deliver results, HCPs, therapy. portion by patients to is than their patients only more their not to commercial solutions identifying greater these for Pharma omni-channel digital more spend

We they continue believe trend RWD-AI, reallocate proof offering well this solutions to to We clearly are commercial a legacy is seeing being momentum are is higher price dollars early digital. as by bodes for for believe smarter a what this looking we the of with pharma RWD-AI this despite highlighted with as newer tag.

the decision added potential. bigger streams with top-down while RWD-AI from us obtaining we makers and greater strategic pharma overall stickier benefit margins a of push growth benefit with moving stronger to has can partner player by a where tactical revenue the from a

focus as as our shows it to and are call, outcome be limited within on activity As which positively, continuing getting at we out we in very area more relevant our in and and We a investing view is are year. pharma’s campaigns. importance as well this spray quickly they an requirements are transparency gain looking and mentioned vendors space to last insights scale, serious clip rapid pray read with will

these believe will level increase data our we platform fact, social the guiding programs pads. engagement EHRs, significant we integrated and market multiple across and In display which on TAM, advantage media, landing our share across has physician a as only are engagement capabilities that provides

up of the level Moreover, deeper today previously is something influence data from derived By our affect we additional physician-level pharma why embracing estimates, physician-level that new day, from every the practices. from spend is reporting was that best the is in be of investment order witnessing are normal unattainable, of data the space. customers. reporting come And for reporting to insights be which with transformational that insights the our quickly campaigns catch can insights digital will our

standards taking this seriously, investments they and health to in is looking as is to sign to that a clear more pharma This scale establish digital and space. new up continue invest more motivation in

utilize stronger completed the landing further for Later efficiently allows on through of and more ability of enhancement and targeting an customers’ to this effectively year, generate enabling have AI platform all our we to smart expect use pads that programs, our ROIs.

and coupled capabilities ROI customers when reach, our our creates against XX:X our further a for platform, the marketing moat will This obtain significant business. their over spend strengthen with our which,

leading dollar far, this a tied agreement of multimillion hub largest during with of year’s Thus a quarter, we deal its EvinceMed. to three-year is and company. closed last Finally, us is the acquisition service for kind the

drug affordability, focused The determining help and support on eligibility accelerate will program. coverage for engagement patient and information pharma-sponsored is access affordability to and

for will And with over financial COO, the Ed Ed? like turn and us QX. the Stelmakh, call that, our through I’d walk to details to CFO who

Ed Stelmakh

and Will, good everyone. Thanks, afternoon,

press the the of Investor available coming which our viewing our website. copy XX-Q, forthcoming section A results downloaded for with our calls, As ended XX, may obtained be the days. additional was Relations And can from be all be March filed with in release XXXX. is a quarter issued first information our will of through and

our to period. the financial Turning for results

Our $XX started was was in the year-on-year headwinds toehold the slight The in same revenue decrease macro XXXX. XXXX. million, period a the have decrease revenues due for since million during from QX in quarter $XX.X QX we recognized to they communicating been

gross mix. of due range. from March in to quarter XX% margin quarter solution channel XX, end ended partner slightly gross slightly The XX, the annual decreased Meanwhile, in ended lower decrease margin XXXX, below XXXX, our was the our March and to XX.X%

XX% continue in expect and come We to between margin gross XX% XXXX. to in

for three from increase XX%. an period and Nearly expenses to and the hires same XX, $XX.X year. increase of in primarily the operating of the was remaining March ended of the $XX.X for higher million for XX% the normalized merit XXXX, increased to XXXX, XXXX combined due payouts stock-based compensation impact the Our tied full the EvinceMed months bonus million a increase increases acquisition, was year few annual and with to

We per of loss a $X.X had loss diluted million of period was during as net net in and diluted period. $X.X ended to loss of for as a XXXX $X.X fully months million XXXX. same $X.XX a fully the loss outstanding, and or net shares $X.XX basic per non-GAAP three the of year for same first basic compared the share to million or a ago fully and basic share $X.X $X.XX the quarter million XXXX, or in On compared diluted non-GAAP XX, March basis, net per

Operating cash and investments in access. to expanded capabilities largely payments $XX,XXX to upfront and flow was of of was due material timing virtually a our growing quarter, fund which breakeven during the loss the

Our XXXX. balance cash short-term and XX, totaling March on XX, equivalents million with million sheet $XX.X December XXXX, cash, strong compared investments in remains to $XX.X

execute to capitalized expand our well strategy and balance sheet and our are organic growth. our believe to us against offerings drive profitable We growth business further positions solution

at compared priorities continuously M&A opportunities valuations when year. to within that more strategic fit also attractive We’re our evaluating last

XXXX, terms for to our XX% outlook the the at company to In revenue full year-over-year. least revenue of expect increase year continues

to our KPIs XXXX. for turn the let’s first Now quarter

And XXXX. XX the don’t the largest now revenue in and their tied as stands XX quarter top vaccines. to the million per we with of of first companies that average manufacturer Our of top of at are top the sales majority pharmaceutical the COVID-XX XXX% of $X pharma XX world have working XX

presence As and solutions, to this opportunity we that a continue I represents a digital piece. believe largest former this segment the commercial of executive, in for pharma industry have the solid

retention XX% in client with we impact factors to at and we held FTE resulting that line calls. what and Our programs declined to several last the net to reported steady our discussed rate revenue prior quarter. $XXX,XXX due per Revenues macroeconomic in the

previous the a are are year. XX-month by the a and the on As reminder, dynamics our calculated KPIs from of rolling headwinds basis impacted

headwinds we our expect subside, these As improvement. show to KPIs

with that, to now, the Will? like call turn back I And over Will. would to

Will Febbo

Q&A. let’s now Operator, to Ed. move Thanks,

Operator

question go [Operator you. with from comes Blair. William Thank ahead. Instructions] Your Ryan Daniels Please first

Jared Haase

taking This afternoon. is Hey. my Good Haase in for Ryan. for questions. Thanks Jared

between impact of we pharma. payers highlighting patient Financial get there starting from to us, in some Assistance just color tension pull First these on some the access. back programs, a manufacturers one maybe know and to report was the recent programs which can regarding an have were hoping obviously and Data I pharma some

curious speak a of what seeing revenue in as just the sort comes And bit little So of tie related today? you maybe you guess you’re could from overall? market I a in point, just what percentage to these your then if could programs

Will Febbo

hear it multiple journey. and hand I’ll pieces Ed It’s Jared. Will. all because and by Hey, a solutions to really a patient second. We towards we’re in solution, have and multiple to where enterprise revenue play don’t Yeah. over Good approach break in they relevant it’s that voice the out moving your

out. that break going to not So

hasn’t accessible But our It business It’s material be piece making important. it’s affordability business. the just to few last a over percentage that basically important we’ve spoken that’s always the and of not will years. a been, of

where I let think for hand Steve patient has specialty going it too. to become medications, where me it’s maybe who’s heading have really it over to the patient to can to is more and then largest in Ed But a HCP kick the the it’s impact specific adherent. and

Ed Stelmakh

Yeah. question. Great Jared. Yeah. Hey, Thanks, Will.

more agree financial financial pharma I be said, what for to at much a the the overall our But for copay well bodes slice steps that targeted more point-of-care. to think in I helps declining need So patients lot just trying of with RWE messaging, Will and for really has identify would mix again, be driven of of more at while. targeted. just that pipe due program the the these been kind It the really -- us specifically solution right to time fact us messaging a by a a lot AI right trends

else know that? So want you to anything Steve, add I don’t if, to

Steve Silvestro

those would from consistent brands to of assistance small consistent value volume massive molecule shift specialty, with household to to just exchange And you’ve that to with the mean, I the need evolve. in the the marketplace programs I got sort shift that, occurring. of to Jared, financial brands, name it’s drugs from sort also Yeah. say,

friction and friction that as it anyway. highlighted, existed, in would to more between payers was the necessitate change and whether dynamics the So and pharma ecosystem from -- the but small specific has or the biologics, not marketplace general copay programs changing just or assistance in there financial molecule Ed always

positioned think, technology on it’s Ed to -- as given really our our capitalize RWD-AI, with I So on we’re a net us it’s that. well said, focus benefit to

though. great Thank question you. So,

Jared Haase

yeah, And to I certainly it. appreciate target the Yeah. ability a differentiator. Got can sense. makes That is

the just Will, you can these of get those back budgets here. largely that business do the at more half or you these guess follow-up if types tactical impacted sales, are things wondering I feel a we swing second most year you think, as sales of like point little set of mean bit in this back? being year? do those the to come how a been of headwinds. that kind that’s I’m I for the by can the think So transitory maybe quickly alluded area maybe of sort I the stability

Will Febbo

Absolutely. Yeah.

be fastest, We of the the worked Good can companies up XX lot tactical They’re media a with, with on is down are budgets who work going So side, those over last and through we’ve news the for that managing pharma. largely right? the brands dialed year. over is it obviously, one agencies.

one So as that’s better, the they macro will dial the the does fastest. get up

calling of half. we’re improvement made not dialed year signs we’re is half The efforts that yet, that that due agencies what early pharma down with some on education helps the largely and seeing we we’re them that’s second would good of double yeah, being that think differentiate So, first very one seeing the really that. doing but a and last really with marketing to be and I the partner just and up in in news is the good call to we’re

still hope the stand half. So second for

Jared Haase

the all Thanks. Great. Okay. Appreciate color.

Will Febbo

you. Thank

Operator

comes go Sean Your next RBC. with question ahead. Dodge from Please

Sean Dodge

tactical just Will, on for Maybe, a moment. staying Thanks.

there Is the QX? comments can progressed there, like share improving. grown? that much give don’t is around pipeline How I guess, sense anything or you maybe of that? I magnitude a there us change Your compared to know for to tactical, of

Will Febbo

Well, stray if me Ed from KPIs. would our mad at I get

Ed Stelmakh

Yeah.

Will Febbo

active am. going give but just you seeing But year-over-year, I strong more year-over-year, pipeline are not or is business year-to-date I’m a to numbers. He already. So mark-to-mark the than we --

awareness this, And conferences September for around about lot Sean, marketing, at agency really last we’ve speaking down within sector. talked that -- events, probably holding brought the August, a training, of and year we doubled up

net-net, clear drive lift up, pharma’s and really access think, helping up enable ROI. catching can our they’re find catching and we’ve patients and of and think what all supplied message I digital I a we script through clients to HCP So in

Sean Dodge

of pretty share Great. you back into proportion or Okay. there can now into I on share quantify half guess, imply Maybe is revenue I’d any imagine being the is Anything us that, you year, via of ramp the contract. on And as can greater it you then year. the a guidance, to steep have of visible deeper we continues into progress kind update that a for visibility of under there? the kind

Will Febbo

start? you Sure. to do Ed, want

Ed Stelmakh

I can take that.

Will Febbo

Sure. Yeah.

Ed Stelmakh

Yeah.

range. typically tracking are how And already Sean, would you? well between, within hey, backlog would XX% So, our now, say, I right signed So basically, to we’re we XX% of see committed. that and

of where So half today. nice on kind of sit that view gives us back a from the the we year

pretty we really backlog healthy at a So like our salad current looks feel to and meet pretty it’s least guidance.

Sean Dodge

far, Okay. over incremental that is all The running or six the RWD deals you QX all of those we signed to are revenue some expectation think kind cadence like beyond that kind when those begin help thus up in about the year? and there now will and flow of

Will Febbo

have last on second very right a now a Yeah. that. key time we year, or They in we a now. I pipeline this are really active think pipeline and for the heavier all of least didn’t piece half at reliant And RWD-AI there. being have At growth robust

gives you -- it half. talked the but even And driver, So as anyway. that’s the growth But, this it’s second then the reliance that’s pop higher that’s what half on more a know, bit then. confidence yeah, is more second us little about year, -- a typical Sean, there’s seasonality, a on as that we’ve

Sean Dodge

again. Thanks Okay.

Will Febbo

Thanks, Sean. next See you week.

Operator

ahead. from question Please next comes Davis SVB. go Stephanie with Your

Stephanie Davis

question. my taking for Thanks guys. Hey,

market, we’ve clients. but First, some just across has I lot about of one out pharma -- peers large pipeline a called questions asked I know your elongation the of

some happening So take we get and the beyond of hoping on I your is view this can why was your macro?

Will Febbo

talk in and to let is thick elongation. cycle sales I’ll him Steve of Well, Sure. the it.

Steve Silvestro

the question. hear Hey, to from Stephanie. Thanks you. for Good

first think, went in this of saw I of mean, bit we four sort going what sort situation financial of with there was a a bit I little was see the pause So, to frankly, -- the the what that on little quarter, waiting on. in

pipeline. seen we’ve post acceleration an on actually What the that is

this try point time see close programs thrilled of relinquish, get is seeing scrambling that. marketing we’re pause is so faster sort and team that to live we’re at So kind shrink to and to of

post sales will what like but cycle the so this in to that point I and any disruption back what like that. shakeout of be cycles, already see to actual line believe in reason have looks in waiting don’t terms again, look We’re with we’re sales there’ll typical here QX at our

In up. interesting dynamic. fact, A are the good great more sales to -- scrambling sort targeting shorten catch cycle also -- on Good is of products starting some our of to of people sophisticated question. kind very as

Stephanie Davis

buy a to So if better Why not and handover intra-quarter. you’re are buyback this? announced little authorization a seeing going shares the backdrop bit you we giant

Will Febbo

are there these things Well, periods. called blackout

follow the to have We rules.

So we we one our authorized, will. we in and we have and stock can, believe obviously when

Stephanie Davis

It’s in clause...

Will Febbo

Yeah. Absolutely…

Stephanie Davis

Right.

Will Febbo

Yeah. blackout when that, a in we But we actually period were so. announced

Stephanie Davis

Okay.

Will Febbo

Yeah.

was quarter, and after that We have that. days five you know, as a announced

So…

Stephanie Davis

Make sense.

Will Febbo

add, just peers shifting to bigger are the Stephanie, for deals, think of one that it. more would I also I just sort aspect decision-makers. Yeah. enterprise sales cycle That’s is this of as they

something is, that well, see company they to may to true. you’re thing that’s other The claiming doing be that’s close when if do it, wants pharma can another

can’t And landscape. so quickly, going said, about saw declutter and year. quickly. them believe pretty of to as present talked and We market last it to show slows to you pretty you’re because it can’t We fade going that that’s sometimes test. we measure down it Steve if that And sort cluttered transparently and certainly you effectiveness,

Stephanie Davis

Thank Very you. Hey. helpful.

Will Febbo

Sure.

Operator

next go ahead. David Stifel. comes from Please Your question Grossman with

David Grossman

could just strategically And those was and trying doing in more couple on just you said, you. you of outside accomplish? to were to beginning comments what remarks. of what to wondering, to your EHR. wanted you’re you expand aggressively that, a you And Thank back one made you’re I go I’m the elaborate prepared

Will Febbo

Will. It’s Dave. Hey, Absolutely.

within patient them the our to that and we access. base how and journey track patient So when we journey to are HCP think you stay connected client about where helping via

on just technology Doctors in They’re different on touch care EHR meetings. team on area. therapeutic are their There’s cell not day, points. right? They’re depending using phones. lot telehealth the of They’re all their a

we’re to go know how landing perspective, API makes from beyond and a our So pad. well, tech because to EHR we company a really as it sense

show down more clients, our we And HCP we sit so much when access. can holistic a around with plan them

piece to all data. while the that on to do is key you And level have transparent being physician this

a a add little that. are that’s early is So, Steve, well maybe clients pretty strategy, good and you it’s I responding think pretty that signs want but to bit, the the to rationale to

Steve Silvestro

Yeah. Hey, David.

I it highlighted think to I essentially the data they’re physicians it’s interactions. at. in And you differentiating point mean will. meeting report little back the key us the where those is terms of for physician ability

So advertisements, going unlike endemic differentiator show be on, sort of what’s provide website and us. to PLD to think I generalized physician ability going a back is the level, the for at key

EHR the heard it’s And you point. a but can do other in in not as we’re looking that platform from, we that, that focal Will, at it’s just that every making

key So from it’s our in peer anybody differentiating going to set, us frankly. point a give

David Grossman

you? one -- and potentially others or buzzword kind being where said, help least you right the AI you I you’ve ad digital it just of of come now. media wondering know buying much and a that going the media is impact hurt potential on it kind your space in at Right. how could it impact business things get up, before about can into And I the But big thing if how generative think, and that’s I’m thing thought on if on is of this those

Will Febbo

is through the we years but everyone interesting. watching and implemented So that’s Yeah. machine for been half right? obviously, two like RWD-AI, truth -- learning We, that, It’s last have we’ve that active. the doing is a

it pipeline. revenue the in have against We

So a it’s dream. not

size has. to company going can network. someday We’re entire the more efficient. And service that remarks I have to the a that prepared already our makes think hoping platform in campaign that for we It any for you heard where brand, our place any enable we’re

marketing, make gets you material, it And avoid and that’s the of sophisticated, and and to it if like commoditization, because better. more need transparent all you more think to space,

need innovate. You to

over we’ve really the couple so last And that of years. down doubled in

think for. this to people going something And be remember that’s really I that company

DNA team the I I think days data last we’re pack. scientists, in could very way of week with ahead I And spent the much already. tell of the it’s and you, of company our two

it better in clinical from support. have from companies obviously note a notetaking seen the and get anywhere have faster. I to -- at So other been These looking going simplifying they’re things it, while decision workflow using for to

it they’re with are someone who’s And the not am I really -- whatever why about, in and totally aren’t as for or people already more. smaller not smarter, workflow. in watching we’re reason is faster, the And could that EHRs paranoid full there come -- we’ve talked looking the but

we’re their place with great partner for So doctor the innovative patient. and in the just and think this be I deliver a solutions good to

David Grossman

back first the now, have of couple doing the and a But RWE big if to so product, the year for what look you’re has cases use there you change? any or ago been you signed deals

Will Febbo

we’re finding effective, wouldn’t otherwise out who medications find clients that They’re like need are It’s there. Yeah. Dave. patients that the unbelievably our

So our the for impactful the obviously, patient, clients. for It’s impactful outcomes. and it’s doctor for

really we us have on message there’s some smarter intel based good -- patent it’s yeah, some So, it’s it’s pending. and up because actually it’s really -- firing a

out. the remarks, but and we certainly cases more building that talk one. I in And on focused have really We’re to think more to we’ll prepared share,

David Grossman

one expenses for went expected. sequentially, we have more looks but I Right. flat, operating relatively would quite maybe GAAP like It stayed And question Ed. up, your just financial comps stock-based think, than

just surprised through, much expenses sequentially? in So up went cost. given topline, on just operating I’m the maybe think on expense, just at was going what’s going expenses But the are these how fixed trying that I with what’s are the to

Ed Stelmakh

Yeah. Yeah.

the if play. few things the look a at you at just OpEx side, on comp, So cash

very increases, [inaudible] all, you’re of up things. year. and few -- has right, a made gone we really couple have Merit of hires First that’s compensation a we few last

year. We also bonuses our this for reset

our know, numbers. you we last As year, missed

full bonuses. out pay we So

XXX%. just this reset for bonuses to year a they’re back So of

as the Will, And well of to expansion footprint, investments mentioned. reporting our related then, channel it’s the as of really some had capabilities secondly, that,

would I at in a look need. slight if the to $XXX,XXX more OpEx run in increase can you So, capture those quarters, just you points expect per to subsequent millions, not it’s say, quarter just rate, continue you

David Grossman

year? So sequential the in you of would expect increase the balance

Ed Stelmakh

also in Yes. topline. we the growth expect But

David Grossman

All Right. Appreciate much. Thanks very right. it. Very good.

Ed Stelmakh

Yeah.

Operator

Your comes Chatterji next Riley. go question from Neil Please B. with ahead.

Neil Chatterji

Hey, guys. afternoon about and for just just questions. platform? taking just Good curious you the give enhancement the I more first, us the color guess, that, smart could targeting thanks on Maybe maybe if talking for you were

Will Febbo

Well, so we’ve don’t this you doctors, a for quick let Steve, just been the while. and overview Why RWD-AI to simple works a really why clients don’t give talking patients. about I for message of why

Steve Silvestro

I Neil. patients Hey, too. is that profiles allows us patient we what in the U.S. essentially, for Happy it we’re the across individual to -- at look of doing ecosystem Yeah. mean,

candidates that So to specific have for function data function enables us we identify with a for an machine then execution take regarding intake and we have clearly data, potential got. interrogate panel and and patient HCP an the action go they’ve therapy that learning to a out an an platform that

through that’s one and And there that of so it’s connected think to got you’ve businesses key all able find, differentiator. other as those the businesses and is unique in business. that’s pull got three analytics components be businesses, together businesses identify, this solely to execute. for that business go execute got now But out, that differentiators and are I this the you have out of you’ve key data Neil

that’s why way just the that’s because could describe And simplest can efficient right, think scale. plug-in you’ve so I effective, really linear Helpful. very it’s that’s got this it. I and

Neil Chatterji

Got it.

that. have might I Okay. misinterpreted

for So year. new later something this there’s not

Steve Silvestro

Okay.

Neil Chatterji

That just…

Will Febbo

No. No.

Steve Silvestro

No.

Will Febbo

Go right. it Go -- -- just Steve. It’s ahead. that’s ahead,

Neil Chatterji

Got it.

Steve Silvestro

Will. ahead, Go No.

Will Febbo

just to that be it just to all it’s network our available was brands I for with. entire to going work expanding say, we

which just trigger better better So and mechanism, a sophisticated ROI. targeting gives more

Neil Chatterji

then for another -- that just here. follow-up Great. clarification. Thanks Great. And just

you the on service hub Just agreement got. that

kind the expected the from impact of on that? curious Just

Will Febbo

hub. $X Yeah. through brand, year It’s about pretty one out and one year spread each that’s a evenly million

a that see scale to good team so of could And And pretty how that. nicely. it’s pretty job. win. did It’s proud easy The we’re a great

we’ve eligibility got affordability. programs that -- hubs, and really patient around and and help the can the it’s assistance patient therefore, programs those And solution a are

So but early it’s right into we place, have to right it ready. it got enough time,

about on So the we’re posted others across we’re to excited everyone keep line. that that. bring very We’ll able

Neil Chatterji

Great. me. it Thanks. That’s for

Will Febbo

Thanks, Neil.

Operator

from Please ahead. [Operator Max Instructions] comes Your Capital go next Michaels Lake Street with question Markets.

Max Michaels

Thanks for quarter weren’t of any major that my we taking of all? in wondering had call I I’m midpoint at first changed conference that you guys. that the the seeing mentioned XXXX, thought question. now last know investments has process year. if Hey, the approach you half

Will Febbo

or the would client’s pharma? Yeah. you Max, mean investments from perspective investments from

Max Michaels

I mean, M&A, the with in healthy market, you’re guess? out be balance broader sheet, I anything it if seeing could technology more improvement, just investment,

Will Febbo

Sure. Yeah.

we’ll be someone process, selective actively through as size situation. looking in discussions are and highly very M&A We for So, said, valuations several great on. going that in targets. Obviously, Ed at we achievable really think but this active year, will have our more be

We’re in investing ourselves.

We’ve We’re best ROI probably, ROI unbelievably to-date. our in really good at got ourselves, when good we that. invest

best-in-class solution So technology expansion. we continue and to invest in in then, reporting, obviously,

the And land expand they client, more reach we are. so it growth or with price and think Max, maintain if improvement, can our of, solutions or or additional and drivers, price it’s physicians then add patients you wherever improve

So we’re investing of in those. three all

Max Michaels

All right. me Thanks. That’s guys. it for

Will Febbo

you. night. Thank good a Have

Operator

time. further There no questions Please are proceed. at this

Will Febbo

our us afternoon. everyone, on thank call this Thanks, update Operator. joining Once for again, you,

We that in expectation before continue with to come will us work the through growth coming quarters. the the opportunities

white deliver customers, the our continue of maintaining continue are vast has space we we to our behalf will dividends to on superior that ROIs focus on sell pay continue to opportunity which to and execution execute product within as into. We against the

our company the current hand. can provide off effectively our we against value of execute venture-type the current Our we represent price valuation returns doesn’t opportunity at I and as trading believe

once plan our intend a program repurchase for authorized As our result, recently trading next up to opens. window we our trading set share

want remind we our OPRX’s everyone propel XXXX of to which I to beyond. in story key and continue strengths, expect will

XX% reaches the U.S. network the in active workflow largest the have more We that of than in prescribers.

increased our substantially prescriber reach Our solutions. to enables cutting-edge outside build the us EHR, landing pads and

AI most future. in positions and for enablement, HCPs a resources the identifies Finally, we customer’s toehold to our our grow is of us foreseeable patients therapies need are believe favorably catching whose which and

are proud sheet, backdrop. execute strong capital We believe our against of, be financial we will operational to positioned bolstered I’m which firmly markets something goals, very our given the and XXXX current balance by is which

positive As for impact years such, look a base patient and stakeholder prescriber to pharma, forward our we to making come. across

earnings look Operator? at call joining for again to joining our the we us forward us Thanks everyone on upcoming call. our and next in today conferences

Operator

sir. you, Thank

today’s provide call, I call. forward-looking during statements regarding the Harbor that like today’s company’s would includes made we Safe Before cautions conclude to important statement

by management may the made Act of of forward-looking during of amended. today’s the as Section of definition Act amended as Section and Securities XXA XXE XXXX XXXX within and statements call Securities Statements the contain

decisions. words similar forward-looking seeking and statements. and should identify date statements These not the used only speak to be investment to possible made. expressions forward-looking that They statements estimate, make may The anticipate, such expect, are

expectations gross include also investments, for estimation market Such the growth, forward-looking this announcements. in opportunities, acquisitions operating addressable technology, the include total penetration, upcoming expenses, profitability, management’s statements revenue cash growth regarding of margin, of the market year. They size, statements call rest flow, and

forward-looking to obligation any statements, of no revise undertakes company because or information, otherwise. publicly or new future The events whether update

or and risks to subject which of inherently are statements predicted be some Forward-looking uncertainties, cannot quantified.

forward-looking or competition government include, risks. limited uncertainties Future materially those of effect from statements forth and The the to, events contemplated subject which forward-looking and these risks to regulation, differ could are underlying actual not material but set by statements. and are and other results to

annual included SEC uncertainties are and sec.gov. on for XXXX. on forward-looking website Risks business Form company’s could XX-K results affect is available and which This XX, are the ended the quarter website subject on company’s in Form the at December financial to to report the and statements

end release like today’s we to Before would remind that starting Please via replay be replay conference, will everyone via this through at company’s today’s I for for to call for this website available press the evening, webcast-only instructions year. www.optimizerx.com. running later a refer available

This today. today’s us joining conference for you concludes Thank call.

You may lines. disconnect your now

OptimizeRx (OPRX) 10 May 232023 Q1 Earnings call transcript